Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor
The importance of the carboxyl-terminal domain of the epidermal growth factor (EGF) receptor and its five autophosphorylation sites in the in vivo interaction and tyrosine phosphorylation of the ras GTPase-activating protein (rasGAP) has been investigated, using NIH 3T3 cells transfected with mutant...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 1993 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/177648 |
| Acceso en línea: | https://hdl.handle.net/2445/177648 |
| Access Level: | acceso abierto |
| Palabra clave: | Proteïnes Proteïna-tirosina-fosfatasa Metabolisme Proteins Protein-tyrosine phosphatase Metabolism |
| id |
ES_1cf6da4e312b2dc4fce69778979980ff |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/177648 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptorSoler Prat, ConcepcióBeguinot, LauraSorkin, AlexanderCarpenter, GrahamProteïnesProteïna-tirosina-fosfatasaMetabolismeProteinsProtein-tyrosine phosphataseMetabolismThe importance of the carboxyl-terminal domain of the epidermal growth factor (EGF) receptor and its five autophosphorylation sites in the in vivo interaction and tyrosine phosphorylation of the ras GTPase-activating protein (rasGAP) has been investigated, using NIH 3T3 cells transfected with mutant EGF receptors. Phosphorylation of rasGAP by EGF receptor mutants, in which one to four autophosphorylation sites (Tyr-1173, -1148, -1086, and -1068) were mutated to phenylalanine, was reduced by 50-60% compared to the wild-type receptor. Elimination of these four autophosphorylation sites by truncation of 123 carboxyl-terminal residues of the EGF receptor paralleled results obtained with point mutants. Substantial inhibition (about 90%) of rasGAP tyrosine phosphorylation by the EGF receptor occurred only when the remaining autophosphorylation site (Tyr-992) was mutated, in the context of this truncated receptor or in the full-length receptor mutated at all four other autophosphorylation sites. However, a point mutation of only Tyr-992 in the full-length receptor suppressed tyrosine phosphorylation of rasGAP only by 50%. In contrast, an EGF receptor lacking the last 214 amino acid residues (Dc214), which encompasses all five autophosphorylation sites, phosphorylated rasGAP to the same extent as the wild-type receptor. However, this truncated receptor was significantly impaired in its capacity to phosphorylate phospholipase C-gamma 1. Interestingly, while EGF receptor autophosphorylation sites are required for EGF-induced rasGAP association with the receptor, maximal phosphorylation of rasGAP by the truncated receptor Dc214 occurred without detectable formation of receptor-rasGAP complexes. Furthermore, the capacity of mutated EGF receptors to bring about focal transformation was correlated with their capacity to phosphorylate rasGAP.American Society for Biochemistry and Molecular Biology1993info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/177648Articles publicats en revistes (Patologia i Terapèutica Experimental)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://www.jbc.org/issue/S0021-9258(20)X6719-6Journal of Biological Chemistry, 1993, vol. 268, num. 29, p. 22010-22019(c) American Society for Biochemistry and Molecular Biology, 1993info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1776482026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| title |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| spellingShingle |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor Soler Prat, Concepció Proteïnes Proteïna-tirosina-fosfatasa Metabolisme Proteins Protein-tyrosine phosphatase Metabolism |
| title_short |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| title_full |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| title_fullStr |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| title_full_unstemmed |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| title_sort |
Tyrosine phosphorylation of ras GTPase activating protein does not require association with the epidermal growth factor receptor |
| dc.creator.none.fl_str_mv |
Soler Prat, Concepció Beguinot, Laura Sorkin, Alexander Carpenter, Graham |
| author |
Soler Prat, Concepció |
| author_facet |
Soler Prat, Concepció Beguinot, Laura Sorkin, Alexander Carpenter, Graham |
| author_role |
author |
| author2 |
Beguinot, Laura Sorkin, Alexander Carpenter, Graham |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
Proteïnes Proteïna-tirosina-fosfatasa Metabolisme Proteins Protein-tyrosine phosphatase Metabolism |
| topic |
Proteïnes Proteïna-tirosina-fosfatasa Metabolisme Proteins Protein-tyrosine phosphatase Metabolism |
| description |
The importance of the carboxyl-terminal domain of the epidermal growth factor (EGF) receptor and its five autophosphorylation sites in the in vivo interaction and tyrosine phosphorylation of the ras GTPase-activating protein (rasGAP) has been investigated, using NIH 3T3 cells transfected with mutant EGF receptors. Phosphorylation of rasGAP by EGF receptor mutants, in which one to four autophosphorylation sites (Tyr-1173, -1148, -1086, and -1068) were mutated to phenylalanine, was reduced by 50-60% compared to the wild-type receptor. Elimination of these four autophosphorylation sites by truncation of 123 carboxyl-terminal residues of the EGF receptor paralleled results obtained with point mutants. Substantial inhibition (about 90%) of rasGAP tyrosine phosphorylation by the EGF receptor occurred only when the remaining autophosphorylation site (Tyr-992) was mutated, in the context of this truncated receptor or in the full-length receptor mutated at all four other autophosphorylation sites. However, a point mutation of only Tyr-992 in the full-length receptor suppressed tyrosine phosphorylation of rasGAP only by 50%. In contrast, an EGF receptor lacking the last 214 amino acid residues (Dc214), which encompasses all five autophosphorylation sites, phosphorylated rasGAP to the same extent as the wild-type receptor. However, this truncated receptor was significantly impaired in its capacity to phosphorylate phospholipase C-gamma 1. Interestingly, while EGF receptor autophosphorylation sites are required for EGF-induced rasGAP association with the receptor, maximal phosphorylation of rasGAP by the truncated receptor Dc214 occurred without detectable formation of receptor-rasGAP complexes. Furthermore, the capacity of mutated EGF receptors to bring about focal transformation was correlated with their capacity to phosphorylate rasGAP. |
| publishDate |
1993 |
| dc.date.none.fl_str_mv |
1993 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/177648 |
| url |
https://hdl.handle.net/2445/177648 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://www.jbc.org/issue/S0021-9258(20)X6719-6 Journal of Biological Chemistry, 1993, vol. 268, num. 29, p. 22010-22019 |
| dc.rights.none.fl_str_mv |
(c) American Society for Biochemistry and Molecular Biology, 1993 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
(c) American Society for Biochemistry and Molecular Biology, 1993 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
American Society for Biochemistry and Molecular Biology |
| publisher.none.fl_str_mv |
American Society for Biochemistry and Molecular Biology |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Patologia i Terapèutica Experimental) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869404252912222208 |
| score |
15,300724 |